Basic Information
Basic information for C21orf62-AS1-209-20aa-4
Peptide Name C21orf62-AS1-209-20aa-4
Genome Position chr21:32785317-32785376[+]
Species Human
Peptide Sequence MVIWYYSLLLLLNLLVANVL
Peptide Length 20
Unique Yes
Grand Average of Hydropathicity 1.995
Relative Molecular Mass 2706.21
Experimental Evidences no
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000655231;C21orf62-AS1-209
Transcript Length 5020
Coding Ability 0.506
DNA Sequence Corresponding to Peptide ATGGTAATTTGGTATTACTCTCTATTACTCCTTCTAAATTTATTAGTTGCCAATGTTCTG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :